Methylphenidate for treating fatigue in palliative cancer care - effect and side effects in real-world data from a palliative care unit.

Methylphenidate is generally effective and well-tolerated for the treatment of CRF in palliative care. However, patients with a short life expectancy (<4 weeks) seem to benefit less from the treatment regardless of age, cancer type and dose.